Overview

Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability

Status:
Completed
Trial end date:
2018-07-17
Target enrollment:
Participant gender:
Summary
The investigators' overall objective with this study is to determine performance characteristics of small intestine permeability measurement using 13C mannitol and 12C (regular) mannitol.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Indomethacin
Lactulose
Mannitol